Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-056044
Filing Date
2021-09-14
Accepted
2021-09-14 19:23:33
Documents
2
Period of Report
2021-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2420
2 POA DOCUMENT poa.txt EX-24.3_1008411 2870
  Complete submission text file 0001209191-21-056044.txt   6909
Mailing Address C/O GENENTECH INC 1 DNA WAY MS 49 SOUTH SAN FRANCISCO CA 94080-4990
Business Address
SCHELLER RICHARD H (Reporting) CIK: 0001214133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40794 | Film No.: 211253741

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Issuer) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations